MSN Laboratories Private Limited Ras Export Data — India (DGFT 2022–2026)

Name: MSN Laboratories Private Limited Ras Export Records India — #4 Exporter, 512 Shipments, $22.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ras

India Pharmaceutical Trade Intelligence

$307.2M1,156 Suppliers176 CountriesHS 30049099

ExportsIndia → UNITED STATES29.3%India → SINGAPORE13.2%

#1 Supplier: CIPLA LIMITED

MSN Laboratories Private Limited — Ras Exporter #4 | $22.3M Trade Value | TransData Nexus | TransData Nexus

MSN Laboratories Private Limited — Ras Exporter Profile

Indian Pharmaceutical Exporter · #4 for Ras · $22.3M export value · DGFT Verified

MSN Laboratories Private Limited is the #4 Indian exporter of Ras with $22.3M in export value and 512 verified shipments. MSN Laboratories Private Limited holds a 7.3% market share in Ras exports across 24 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.

MSN Laboratories Private Limited — Ras Export Profile: Buyers & Destinations

MSN Laboratories Private Limited Ras export treemap — buyers and destination countries | TransData Nexus

Where Does MSN Laboratories Private Limited Export Ras?

Country	Value	Shipments	Share
COLOMBIA	$7.5M	267	39.6%
UNITED STATES	$4.4M	122	23.5%
SAUDI ARABIA	$1.4M	31	7.3%
NETHERLANDS	$1.0M	94	5.4%

Who Are the Top Buyers of Ras from MSN Laboratories Private Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	COLOMBIA	$6.9M	292
NOVADOZ PHARMACEUTICALS LLC	UNITED STATES	$2.1M	61
TO THE ORDER	COLOMBIA	$1.8M	78
MSN LABS AMERAICAS SAS	COLOMBIA	$1.4M	39
MSN LABS AMERICAS SASNIT	COLOMBIA	$1.2M	45
MSN LABS AMERICAS SAS	COLOMBIA	$1.1M	58
BOSTON ONCOLOGY ARABIA	SAUDI ARABIA	$649.1K	16
PIEX SAS	FRANCE	$421.2K	15
TO THE ORDER OF.,	JAMAICA	$257.1K	17
BROCACEF HEALTHCARE LOGISTICS BV	NETHERLANDS	$235.2K	24

MSN Laboratories Private Limited supplies Ras to 79 buyers globally. The largest buyer is TO THE ORDER OF (COLOMBIA), followed by NOVADOZ PHARMACEUTICALS LLC (UNITED STATES) and TO THE ORDER (COLOMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ras Formulations Does MSN Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
DISMIGRAS 40 (ROSUVASTATIN 40MG) 3X10	$658.7K	24
LURASIDONE TAB 80MG 30 NOVADOZ	$477.0K	13
(MSN PHARMACEUTICAL) DISMIGRAS 40 (ROSUV	$443.8K	13
DISMIGRAS 40MG 3X10-INST MSN -CO	$387.5K	8
(MSN PHARMACEUTICALS) DISMIGRAS 40 (ROSU	$351.5K	12
MSN PHARMA-DISMIGRAS 20 (ROSUVASTATIN 20	$350.0K	7
(MSN PHARMACEUTICALS) DISMIGRAS 20 (ROSU	$349.1K	7
DISMIGRAS 40 ROSUVASTATIN 40MG 3X10 AS PER DOCUMENT	$286.3K	9
LURASIDONE TAB 60MG 30 NOVADOZ	$284.6K	9
PRASUGREL TABLETS 10MG X 98	$266.7K	14

MSN Laboratories Private Limited exports 502 distinct Ras formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DISMIGRAS 40 (ROSUVASTATIN 40MG) 3X10 with 24 shipments worth $658.7K.

How Does MSN Laboratories Private Limited Compare to Nearest Ras Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	INTAS PHARMACEUTICALS LIMITED	$36.5M	731	28	$50.0K
4	MSN LABORATORIES PRIVATE LIMITED ★	$22.3M	512	24	$43.5K
3	MYLAN LABORATORIES LIMITED	$20.1M	402	16	$50.0K
1	CIPLA LIMITED	$8.3M	166	21	$50.0K

MSN Laboratories Private Limited ranks #4 among 1156 Indian Ras exporters. Average shipment value of $43.5K compared to the market average of $106.8K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Ras Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,417	9.4%
DELHI AIR CARGO ACC (INDEL4)	1,335	8.9%
NHAVA SHEVA SEA (INNSA1)	947	6.3%
SAHAR AIR	935	6.2%
DELHI AIR	709	4.7%
Bombay Air	648	4.3%
AHEMDABAD AIR ACC (INAMD4)	528	3.5%
TUTICORIN SEA (INTUT1)	406	2.7%

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Ras Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)

In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.

MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ras shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 895 individual customs records matching MSN Laboratories Private Limited exporting Ras, covering 502 formulations to 34 countries via 79 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 176+ countries, 2,323+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ras

Ras

MSN Laboratories Private Limited — Ras Exporter Profile

MSN Laboratories Private Limited — Ras Export Profile: Buyers & Destinations

Where Does MSN Laboratories Private Limited Export Ras?

Who Are the Top Buyers of Ras from MSN Laboratories Private Limited?

What Is India's Total Ras Export Value and How Much Does MSN Laboratories Private Limited Contribute?

What Is the Average Shipment Value for MSN Laboratories Private Limited's Ras Exports?

How Does MSN Laboratories Private Limited Compare to Other Indian Ras Exporters?

What Ras Formulations Does MSN Laboratories Private Limited Export?

Regulatory Requirements: Exporting Ras to Key Markets

United States — FDA

How Does MSN Laboratories Private Limited Compare to Nearest Ras Exporters?

Which Indian Ports Ship Ras Exports?

What Other Ayurvedic & Herbal Products Products Does MSN Laboratories Private Limited Export?

Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Ras Exports

MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards

About MSN Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ras Export Data from MSN Laboratories Private Limited

Ras Stats

Company Overview

Top Products by MSN Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source